The potential of CYP2D6 phenotyping to improve opioid dosing strategies
Ridley Cassidy, Ewan Main
doi: https://doi.org/10.1101/2021.10.07.21264057
Ridley Cassidy
School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom
Ewan Main
School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom
Data Availability
All data can be made available for use upon request
Posted October 07, 2021.
The potential of CYP2D6 phenotyping to improve opioid dosing strategies
Ridley Cassidy, Ewan Main
medRxiv 2021.10.07.21264057; doi: https://doi.org/10.1101/2021.10.07.21264057
Subject Area
Subject Areas
- Addiction Medicine (376)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2781)
- Dermatology (237)
- Emergency Medicine (418)
- Epidemiology (12432)
- Forensic Medicine (10)
- Gastroenterology (787)
- Genetic and Genomic Medicine (4298)
- Geriatric Medicine (397)
- Health Economics (705)
- Health Informatics (2776)
- Health Policy (1029)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (406)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4073)
- Nursing (218)
- Nutrition (603)
- Oncology (2155)
- Ophthalmology (609)
- Orthopedics (252)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (79)
- Pathology (480)
- Pediatrics (1152)
- Primary Care Research (473)
- Public and Global Health (6679)
- Radiology and Imaging (1457)
- Respiratory Medicine (889)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (172)